Skip to main contentSkip to navigation
Sirius Investors
Raia Drogasil S.A.

Raia Drogasil S.A.

RADLY
OTCConsumer Defensive

Raia Drogasil S.A. (RADLY) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Raia Drogasil S.A.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
29.68
Moderate
WeakModerateStrong
P/B Ratio
5.27
Weak
WeakModerateStrong
Earnings Yield
3.36%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
17.71%
Strong
WeakModerateStrong
Operating Margin
5.96%
Weak
WeakModerateStrong
Net Profit Margin
2.93%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
11.62%
Strong
WeakModerateStrong
Net Income Growth
6.15%
Weak
WeakModerateStrong
EPS Growth
5.48%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.46
Moderate
WeakModerateStrong
Quick Ratio
0.52
Weak
WeakModerateStrong
Asset Turnover
1.74x
Strong
WeakModerateStrong
Inventory Turnover
3.48x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
2.66%
Weak
WeakModerateStrong
EV / Free Cash Flow
45.68x
Weak
WeakModerateStrong
Net Debt / EBITDA
1.79x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.549
Weak
WeakModerateStrong
Return on Invested Capital
14.09%
Weak
WeakModerateStrong
Cash Conversion Cycle
67.83 days
Weak
WeakModerateStrong

Fortress screener guardrails

0/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for RADLY.

View Financial Statements